American National Insurance’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

American National Insurance’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-152,550	Closed	-$1.81M	–	383
2017 Q2	$1.81M	Hold	152,550	–	–	0.1%	199
2017 Q1	$2.25M	Hold	152,550	–	–	0.13%	185
2016 Q4	$2.47M	Hold	152,550	–	–	0.14%	171
2016 Q3	$2.77M	Hold	152,550	–	–	0.16%	170
2016 Q2	$2.51M	Buy	152,550 +14,900	+11%	+$241K	0.15%	178
2016 Q1	$2.28M	Sell	137,650 -525	-0.4%	-$9.19K	0.14%	189
2015 Q4	$2.99M	Buy	+138,175	New	+$2.69M	0.18%	160

Other funds holding HZNP

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BGIM

Brandywine Global Investment Management Philadelphia, Pennsylvania $14.9B AUM 20.41% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

American National Insurance's HZNP Position: Q3 2017 in Review

American National Insurance sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q3 2017, closing a stake of 152,550 shares — an estimated $1.81M sold.

American National Insurance first reported a position in HZNP in Q4 2015 and held it in 7 quarters. The position peaked at $2.99M in Q4 2015. 181 funds tracked by Wall St. Rank hold HZNP as of Q3 2017.

American National Insurance reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q3 2017 after selling out during the quarter.
American National Insurance sold 152,550 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q3 2017, an estimated $1.81M.
American National Insurance first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2015 and held it in 7 quarters.
American National Insurance's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $2.99M in Q4 2015.
181 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q3 2017.

Based on American National Insurance's 13F filing for Q3 2017, filed 13 Nov 2017.